Mimedx (MDXG) Times Interest Earned (2011 - 2026)
Mimedx (MDXG) posted Times Interest Earned of -$47.84 for Q2 2026, down 19.83% sequentially from -$39.92 in Q1 2026, and down 344.03% YoY from $19.6 in Q2 2025.
Mimedx (MDXG) Times Interest Earned (2011 - 2026) Analysis & Trends
Mimedx has reported Times Interest Earned for 16 years, with the latest figure at -$47.84 in Q2 2026.
- Quarterly Times Interest Earned fell 344.03% year-over-year to -$47.84 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $11.21 (down 83.49% YoY) and the FY2025 annual result came in at $5.76, down 61.44% from the prior year.
- Times Interest Earned eased to -$47.84 in Q2 2026 per MDXG's latest filing, from -$39.92 in the prior quarter.
- Over five years, Times Interest Earned peaked at $30.36 in Q3 2025 and troughed at -$47.84 in Q2 2026.
- A 5-year average of $1.2 and a median of $6.3 in 2022 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2024: Times Interest Earned sank 2203.64% in 2022, then surged 2645.88% in 2024.
- Over 5 years, Times Interest Earned stood at $6.23 in 2022, then jumped by 43.76% to $8.96 in 2023, then slumped by 271.61% to -$15.37 in 2024, then soared by 292.55% to $29.6 in 2025, then slumped by 261.61% to -$47.84 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$47.84, -$39.92, and $29.6 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Mimedx | 622.24 Mn | 486.40 Mn | 44.38 Mn | -47.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -47.84 |
| Mar 31, 2026 | -39.92 |
| Dec 31, 2025 | 29.60 |
| Sep 30, 2025 | 30.36 |
| Jun 30, 2025 | 19.60 |
| Mar 31, 2025 | 13.48 |
| Dec 31, 2024 | -15.37 |
| Sep 30, 2024 | 6.36 |
| Jun 30, 2024 | 13.59 |
| Mar 31, 2024 | 5.56 |
| Dec 31, 2023 | 8.96 |
| Sep 30, 2023 | 6.61 |
| Jun 30, 2023 | 6.65 |
| Mar 31, 2023 | -0.22 |
| Dec 31, 2022 | 6.23 |
| Sep 30, 2022 | -5.59 |
| Jun 30, 2022 | -8.31 |
| Mar 31, 2022 | -8.14 |
| Dec 31, 2021 | 1.09 |
| Sep 30, 2021 | -0.92 |